YB-1: The key to personalised prostate cancer management?
Mark Bates, Anna Boland, Niamh McDermott, Laure Marignol
Abstract
Y-box-binding protein 1 (YB-1) is a DNA/RNA binding protein increasingly implicated in the regulation of cancer cell biology. Normally located in the cytoplasm, nuclear localisation in prostate cancer is associated with more aggressive, potentially treatment-resistant disease. This is attributed to the ability of YB-1 to act as a transcription factor for various target genes associated with androgen receptor signalling, survival, DNA repair, proliferation, invasion, differentiation, angiogenesis and hypoxia. This review aims to examine the clinical potential of YB-1 in the detection and therapeutic management of prostate cancer.
Topics & Concepts
Prostate cancerCancer researchTranscription factorAngiogenesisCancerBiologyProstateAndrogen receptorCancer cellDiseaseGeneBioinformaticsMedicineInternal medicineGeneticsRNA Research and SplicingUbiquitin and proteasome pathwaysHeat shock proteins research